Business and Finance Business and Finance
Mon, December 13, 2010
Sun, December 12, 2010
Fri, December 10, 2010

Bull & Lifshitz, LLP Announces Investigation of the Acquisition of Center Financial Corporation


Published on 2010-12-10 18:20:51 - Market Wire
  Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Bull & Lifshitz, LLP announces an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of Center Financial Corporation (NASDAQ: CLFC) (referred to as "Center Financial" or the aCompanya) by Nara Bancorp, Inc. (aNara Bancorpa) in a stock-for-stock transaction valued at approximately $285.7 million.

Under the terms of the definitive merger agreement, Center Financial shareholders will receive a fixed ratio of 0.7804 of a share of Nara Bancorp common stock in exchange for each share of Center Financial common stock they own.

Bull & Lifshitz, LLP's investigation is focused on whether the proposed deal provides adequate value to the Companya™s shareholders. If you are a holder of Center Financial stock and want to discuss your legal rights, you may e-mail or call Bull & Lifshitz, LLP who will, without obligation or cost to you, attempt to answer your questions.

If you are a shareholder of Center Financial and would like more information about our investigation, please contact Peter D. Bull, Esq. by telephone at (866) 313-6222 or by sending an e-mail including your contact information to: [ counsel@nyclasslaw.com ]. All e-mail correspondence should make reference to Center Financial.

Bull & Lifshitz, LLP is a New York City-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please visit our website at [ www.nyclasslaw.com ].

ATTORNEY ADVERTISING. © 2010 Bull & Lifshitz, LLP. The law firm responsible for this advertisement is Bull & Lifshitz, LLP, 18 East 41st Street, New York, New York 10017, (212) 213-6222. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contributing Sources